Multimodality Imaging for the Staging of Pancreatic Cancer

Surg Oncol Clin N Am. 2021 Oct;30(4):621-637. doi: 10.1016/j.soc.2021.06.006. Epub 2021 Jul 22.

Abstract

Imaging plays a key role in the diagnosis, staging, and follow-up of pancreatic ductal adenocarcinoma. The pancreatic protocol dual-phase multidetector computed tomography scan is the imaging modality of choice. A computed tomography scan is highly accurate for pancreatic tumor detection, assessment of resectability, and detection of metastatic disease. This article reviews key principles of the acquisition, interpretation, and reporting of pancreatic ductal adenocarcinoma imaging with computed tomography scanning and highlights potential roles for newer and supplemental imaging technologies. We discuss the importance of structured interpretation and reporting for providing the most complete and accurate assessment of tumor stage and resectability.

Keywords: Computed tomography; Indeterminate liver lesions; Magnetic resonance imaging; Neoadjuvant therapy; Pancreatic cancer; Staging; Structured reporting.

Publication types

  • Review

MeSH terms

  • Carcinoma, Pancreatic Ductal* / diagnostic imaging
  • Carcinoma, Pancreatic Ductal* / pathology
  • Humans
  • Multimodal Imaging
  • Neoplasm Staging
  • Pancreatic Neoplasms* / diagnostic imaging
  • Pancreatic Neoplasms* / pathology
  • Tomography, X-Ray Computed